Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Peter Drobac"'
Autor:
Neil Gupta, Lisa R. Hirschhorn, Felix C. Rwabukwisi, Peter Drobac, Felix Sayinzoga, Cathy Mugeni, Fulgence Nkikabahizi, Tatien Bucyana, Hema Magge, Daniel M. Kagabo, Evrard Nahimana, Dominique Rouleau, Amelia VanderZanden, Megan Murray, Cheryl Amoroso
Publikováno v:
BMC Public Health, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Rwanda has dramatically reduced child mortality, but the causes and sociodemographic drivers for mortality are poorly understood. Methods We conducted a matched case-control study of all children who died before 5 years of age in
Externí odkaz:
https://doaj.org/article/da2f745bff3143daa205bad270489443
Autor:
Cheryl L. Amoroso, Marie Paul Nisingizwe, Dominique Rouleau, Dana R. Thomson, Daniel M. Kagabo, Tatien Bucyana, Peter Drobac, Fidele Ngabo
Publikováno v:
BMC Pediatrics, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Sustained investments in Rwanda’s health system have led to historic reductions in under five (U5) mortality. Although Rwanda achieved an estimated 68% decrease in the national under U5 mortality rate between 2002 and 2012, acco
Externí odkaz:
https://doaj.org/article/f336e6d32fab46e89bfd1e1beeb34ee0
Autor:
Felix Cyamatare Rwabukwisi, Ayaga A. Bawah, Sarah Gimbel, James F. Phillips, Wilbroad Mutale, Peter Drobac, the AHI PHIT Partnership Collaborative
Publikováno v:
BMC Health Services Research, Vol 17, Iss S3, Pp 77-89 (2017)
Abstract Background Achieving the United Nations Sustainable Development Goals in sub-Saharan Africa will require substantial improvements in the coverage and performance of primary health care delivery systems. Projects supported by the Doris Duke C
Externí odkaz:
https://doaj.org/article/4be2b2d9b5d04ab4a7b5e3af2a9a7f0e
Autor:
Evrard Nahimana, Ryan McBain, Anatole Manzi, Hari Iyer, Alice Uwingabiye, Neil Gupta, Gerald Muzungu, Peter Drobac, Lisa R. Hirschhorn
Publikováno v:
Global Health Action, Vol 9, Iss 0, Pp 1-7 (2016)
Background: Performance-based financing (PBF) has demonstrated a range of successes and failures in improving health outcomes across low- and middle-income countries. Evidence indicates that the success of PBF depends, in large part, on the model sel
Externí odkaz:
https://doaj.org/article/94a9165e55b14c3cbd0b314daddfcd62
Autor:
Jennifer Furin, Medea Gegia, Carole Mitnick, Michael Rich, Sonya Shin, Mercedes Becerra, Peter Drobac, Paul Farmer, Rocio Hurtado, J Keith Joseph, Salmaan Keshavjee, Iagor Kalandadze
Publikováno v:
Bulletin of the World Health Organization, Vol 90, Iss 1, Pp 63-66 (2012)
PROBLEM: The category II retreatment regimen for management of tuberculosis in previously treated patients was first introduced in the early 1990s. It consists of 8 months of total therapy with the addition of streptomycin to standard first-line medi
Externí odkaz:
https://doaj.org/article/0caac8113dad40ca955df1dabae09c75
Autor:
Jennifer Furin, Alena Skrahina, James A Seddon, Jay Achar, Iveta Ozere, Mar'iandyshev Ao, Elena Yablokova, Muhammad Osman, Anthony J. Garcia-Prats, Elizabeth P. Harausz, Mercedes C. Becerra, Peter Drobac, H. Simon Schaaf, Farhana Amanullah, Robert M. Hicks, Petros Isaakidis, D. I. Chiotan, Brittany K. Moore, Pennan M. Barry, N. Sarita Shah, Anneke C. Hesseling, Jennifer Flood, Medea Gegia
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 25, Iss 3, Pp 441-450 (2019)
Emerging Infectious Diseases, Vol 25, Iss 3, Pp 441-450 (2019)
Children had better treatment outcomes and lower mortality rates than adults.
Extensively drug-resistant tuberculosis (XDR TB) has extremely poor treatment outcomes in adults. Limited data are available for children. We report on clinical manife
Extensively drug-resistant tuberculosis (XDR TB) has extremely poor treatment outcomes in adults. Limited data are available for children. We report on clinical manife
Autor:
Ashwin Vasan, Andrew Ellner, Stephen D Lawn, Neil Gupta, Manzi Anatole, Peter Drobac, Tom Nicholson, Sandy Gove, Kwonjune Seung, David Mabey, Paul Farmer
Publikováno v:
The Lancet Global Health, Vol 1, Iss 6, Pp e321-e323 (2013)
Externí odkaz:
https://doaj.org/article/17abe69024414c61a3211250cbc5a393
Autor:
Agnès Binagwaho, Mary C Smith Fawzi, Peter Drobac, Molly Franke, Louise Ivers, Jim Yong Kim, Joia Mukherjee, Julia Noguchi, Michael Rich, Sara Stulac, Paul Farmer
Publikováno v:
Bulletin of the World Health Organization, Vol 87, Iss 8, Pp a-b (2009)
Externí odkaz:
https://doaj.org/article/02800b62e04f452e84f7f7c68a2ebd5a
Publikováno v:
Reimagining Global Health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0e8e18c2ea91989584b4dd22fe61b62
https://doi.org/10.1525/9780520954632-008
https://doi.org/10.1525/9780520954632-008
Autor:
Else Marais, Jennifer Flood, Anna Turkova, Natasha Rybak, Anthony J. Garcia-Prats, Shabir A. Madhi, James A Seddon, Nesri Padayatchi, Elizabeth P. Harausz, Alena Skrahina, Bhanu Williams, Begoña Santiago-Garcia, Ana Méndez-Echevarría, Brittany K. Moore, Lee Fairlie, Sangeeta Sharma, Jay Achar, Parpieva Nargiza, Mar'iandyshev Ao, Martin van den Boom, Antoni Soriano-Arandes, Medea Gegia, Peter Drobac, Tjip S. van der Werf, Elena Yablokova, Stephanie Law, Dennis Falzon, Tae Sun Shim, Anneke C. Hesseling, Beate Kampmann, Jennifer Furin, Jae-Joon Yim, Saleem ur-Rehman, Iveta Ozere, Edward D. Chan, Mercedes C. Becerra, Robert M. Hicks, H. Simon Schaaf, N. Sarita Shah, Farhana Amanullah, Petros Isaakidis, D. I. Chiotan, Pei Chun Chan, Pennan M. Barry, Tamara Kredo, S. M. Kadri, Dick Menzies, Aldo Crossa, Marieke J. van der Werf
Publikováno v:
PLOS MEDICINE, 15(7):1002591. PUBLIC LIBRARY SCIENCE
PLoS Medicine, Vol 15, Iss 7, p e1002591 (2018)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
PLoS Medicine
PLoS Medicine, Vol 15, Iss 7, p e1002591 (2018)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
PLoS Medicine
Background An estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacterium tuberculosis resistant to isoniazid and rifampin) each year. Little is known about the optimal treatment for these children. Methods and findings
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ae06006b893aedb1be3c9fd07ec639b
https://research.rug.nl/en/publications/a320f141-e6e7-45cc-8d2d-96c95cd53eb6
https://research.rug.nl/en/publications/a320f141-e6e7-45cc-8d2d-96c95cd53eb6